Juan whyte

A perfusion fMRI study of the neural correlates of sustained-attention and working-memory deficits in chronic traumatic brain injury. Neurorehabil Neural Repair, 26 7 , Methylphenidate modulates sustained attention and cortical activation in survivors of traumatic brain injury: A perfusion fMRI study. Psychopharm, 1 , Neuroimage, 31 1 , Lehtonen, S. Whyte, J. Neuropsychological outcome and community re-integration following traumatic brain injury: the impact of frontal and non-frontal lesions.

Brain Injury, 19 4 , Malec, J. Structured interview to improve the relilability and psychometric integrity of the disability rating scale Arch Phys Med Rehabil, 93 9 , Marquez de la Plata, C. Diaz-Arrastia, R. Impact of age on long-term recovery from traumatic brain injury. Arch Phys Med Rehabil, 89 5 , Martin, R.

Am J Phys Med Rehabil, 86 8 , Mayer, N. Morgenroth, D. Academic physiatry: vignettes of rewarding careers. Nakase-Richardson, R. Arch Phys Med Rehabil, 94 10 , Walker, W. J Neurotrauma, 29 1 , Ratcliff, J. Wright, D. Gender and traumatic brain injury: do the sexes fare differently? Brain Injury, 21 10 , Schwartz, M. Arch Phys Med Rehabil, 86 9 , Seel, R. Zasler, N. Assessment scales for disorders of consciousness: evidence-based recommendations for clinical practice and research. Arch Phys Med Rehabil, 91 12 , Segal, M.

The accuracy of artificial neural networks in predicting long-term outcome after traumatic brain injury. J Head Trama Rehabil, 21 4 , Neuroanatomic basis of impaired self-awareness after traumatic brain injury: findings from early computed tomography. J Head Trama Rehabil, 20 4 , — Tustison, N. Logical circularity in voxel-based analysis: Normalization strategy may induce statistical bias. Human Brain Mapping. Vaccaro, M. Internet use and interest among individuals with traumatic brain injury: A consumer survey.

Disability and Rehabil, 2 2 , Warden, D. Zitnay, G. Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. J Neurotrauma, 23 10 , — Whiteneck, G. Quantifying handicap: a new measure of long-term rehabilitation outcomes. Arch Phys Med Rehabil, 73 6 , Training and retention of rehabilitation researchers. Using treatment theory to refine the designs of brain injury rehabilitation treatment effectiveness studies.

J Head Trama Rehabil, 21 2 , Treatments to enhance recovery from the vegetative and minimally conscious states: ethical issues surrounding efficacy studies. Am J Phys Med Rehabil, 86 2 , A grand unified theory of rehabilitation We Wish! Directions in brain injury research: From concept to clinical implementation. Neuropsychol Rehabil, 19 6 , Pharmacologic treatment of cognitive and behavioral sequelae of traumatic brain injury: practicing in the absence of strong evidence.

Eur J Phys Rehabil Med, 46 4 , Comment on J Head Trauma Rehabil, 28 2 , — Neurology, 82 13 , Advancing the evidence base of rehabilitation treatments: A developmental approach. Development of a theory-driven rehabilitation treatment taxonomy: conceptual issues.

Why te, J. A phased developmental approach to neurorehabilitation research: The science of knowledge building. Eifert, B. Predictors of short-term outcome in brain-injured patients with disorders of consciousness. Prog Brain Res, , Measuring sustained attention after traumatic brain injury: differences in key findings from the sustained attention to response task SART. Neuropsychologia, 44 10 , No one will ever know the effort, the heartache, the highs, the lows … but here he is my survivor, my warrior on the move to conquer life again!

Each and every day we continue pushing and pushing harder again. I am so proud of you Juan. But I am always here, steadfast in love, support, and mean hardass encouragement! I love you endlessly.

Keep up the work Wallace Wallace Wallace! Juan has been the sole breadwinner he and his wife first married. The family is now doing all they can to make ends meet and support Juan in his recovery. On Sept. Their love for each other keeps them together through this most trying of times.

Donate Now. Celeste Revuelta. In this role, Dr. Whyte leads efforts to develop and expand strategic partnerships that create meaningful change around important and timely public health issues. He has been a leading voice in addressing the COVID pandemic, being named as one of the top 20 health influencers. Whyte is also a major contributor to iterating digital platforms from simply providing content, to instead playing a pivotal role in connecting to care.

He frequently speaks on evaluating digital tools and technologies, assessing their roles in the evolving health ecosystem. Prior to WebMD, Dr. Food and Drug Administration. Whyte spearheaded numerous efforts to address diversity in drug development programs especially as it relates to necessary changes in clinical trial design. This includes strategies around patient recruitment and acquisition, as well as the use of adaptive clinical trial design and master protocols.

Whyte also helped provide regulatory insight into the potential uses of real-world evidence in regulatory decisions, especially around patient-focused drug development.

Whyte led a research agenda around drug safety issues, including prescription and over-the-counter products.